CIAS
GILD icon

Capital Investment Advisory Services’s Gilead Sciences GILD Stock Holding History

Capital Investment Advisory Services’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$786K Sell
6,218
-220
-3% -$29K 0.05% 350
2026
Q1 		$897K Buy
6,438
+51
+0.8% +$7.14K 0.07% 277
2025
Q4 		$784K Sell
6,387
-482
-7% -$58.6K 0.06% 297
2025
Q3 		$763K Buy
6,869
+188
+3% +$21.4K 0.06% 287
2025
Q2 		$741K Sell
6,681
-273
-4% -$29.1K 0.06% 276
2025
Q1 		$779K Sell
6,954
-2,558
-27% -$264K 0.07% 247
2024
Q4 		$879K Sell
9,512
-422
-4% -$38K 0.08% 205
2024
Q3 		$833K Sell
9,934
-721
-7% -$55K 0.08% 219
2024
Q2 		$731K Sell
10,655
-2,441
-19% -$163K 0.08% 227
2024
Q1 		$959K Sell
13,096
-212
-2% -$16.3K 0.1% 198
2023
Q4 		$1.08M Buy
13,308
+820
+7% +$63.8K 0.1% 177
2023
Q3 		$936K Buy
12,488
+743
+6% +$57.1K 0.09% 188
2023
Q2 		$905K Buy
11,745
+245
+2% +$19.5K 0.09% 186
2023
Q1 		$954K Sell
11,500
-1,610
-12% -$133K 0.11% 169
2022
Q4 		$1.13M Buy
13,110
+517
+4% +$40.9K 0.13% 143
2022
Q3 		$777K Buy
12,593
+991
+9% +$62.5K 0.1% 176
2022
Q2 		$717K Buy
11,602
+626
+6% +$38.8K 0.09% 200
2022
Q1 		$653K Buy
10,976
+1,203
+12% +$76.9K 0.07% 233
2021
Q4 		$710K Buy
9,773
+127
+1% +$8.75K 0.08% 219
2021
Q3 		$674K Buy
9,646
+503
+6% +$35.3K 0.09% 214
2021
Q2 		$630K Buy
9,143
+2,252
+33% +$150K 0.08% 244
2021
Q1 		$445K Buy
6,891
+73
+1% +$4.71K 0.06% 267
2020
Q4 		$397K Buy
6,818
+19
+0.3% +$1.15K 0.06% 283
2020
Q3 		$430K Sell
6,799
-265
-4% -$18.4K 0.08% 223
2020
Q2 		$544K Sell
7,064
-3,598
-34% -$276K 0.11% 173
2020
Q1 		$797K Buy
10,662
+5,403
+103% +$373K 0.19% 112
2019
Q4 		$342K Sell
5,259
-349
-6% -$22.7K 0.09% 212
2019
Q3 		$355K Buy
5,608
+221
+4% +$14.4K 0.1% 188
2019
Q2 		$350K Sell
5,387
-12,889
-71% -$848K 0.11% 198
2019
Q1 		$1.19M Sell
18,276
-4,684
-20% -$311K 0.44% 42
2018
Q4 		$1.44M Sell
22,960
-1,633
-7% -$114K 0.61% 29
2018
Q3 		$1.9M Buy
24,593
+292
+1% +$22.1K 0.89% 25
2018
Q2 		$1.72M Sell
24,301
-1,242
-5% -$87.7K 0.86% 26
2018
Q1 		$1.93M Buy
25,543
+1,419
+6% +$113K 1.07% 21
2017
Q4 		$1.73M Buy
24,124
+2,976
+14% +$226K 1.01% 20
2017
Q3 		$1.71M Buy
21,148
+11,900
+129% +$910K 1.05% 20
2017
Q2 		$655K Sell
9,248
-2,204
-19% -$147K 0.43% 62
2017
Q1 		$778K Sell
11,452
-49
-0.4% -$3.45K 0.57% 44
2016
Q4 		$824K Buy
+11,501
New +$855K 0.71% 35

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM

Capital Investment Advisory Services's GILD Position: Q2 2026 in Review

Capital Investment Advisory Services reduced its Gilead Sciences (GILD) stake by 3.4% in Q2 2026, selling an estimated $29K and leaving 6,218 shares worth $786K. The position accounts for 0.05% of the portfolio, ranked #350.

Capital Investment Advisory Services first reported a position in GILD in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.93M in Q1 2018. 956 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Capital Investment Advisory Services held 6,218 shares of Gilead Sciences worth $786K as of Q2 2026.
  • Capital Investment Advisory Services sold 220 Gilead Sciences shares in Q2 2026, an estimated $29K.
  • Gilead Sciences made up 0.05% of Capital Investment Advisory Services's portfolio in Q2 2026, its #350 holding.
  • Capital Investment Advisory Services first reported a position in Gilead Sciences in Q4 2016 and has held it in 39 quarters since.
  • Capital Investment Advisory Services's Gilead Sciences position peaked at $1.93M in Q1 2018.
  • 956 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Capital Investment Advisory Services's 13F filing for Q2 2026, filed 23 Jul 2026.